Therefore, genetic testing can help identify patients with pathogenic EIF2AK4 variants early and may facilitate timely PVOD/PCH diagnosis and referral for lung transplantation before their conditions deteriorate. The gene discussed is EIF2AK4; the disease is pulmonary venoocclusive disease.